IP Library Granted Patent US 11,491,446
Granted Patent B2
US 11,491,446 · App. 16/088,347 · Granted Nov 8, 2022

Virus removal membrane and method for manufacturing virus removal membrane

Inventors: Akika Futamura (Tokyo, JP); Yusuke Kon (Tokyo, JP); Tomoko Hongo (Tokyo, JP)
Assignee: ASAHI KASEI MEDICAL CO., LTD.
B01D65/10B01D67/0011B01D67/0016B01D69/02B01D69/06B01D69/081B01D69/141B01D71/10D01D5/24D01F2/04B01D2325/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,491,446
App. No.
16/088,347
Granted
Nov 8, 2022
Kind
B2
Abstract

A virus removal membrane includes cellulose, and a primary-side surface through which the protein-containing solution is to be applied and a secondary-side surface from which a permeate that has permeated the virus removal membrane is to be flowed, wherein a bubble point is 0.5 MPa or more and 1.0 MPa or less; and when a solution containing gold colloids having a diameter of 30 nm is applied through the primary-side surface to the virus removal membrane to allow the virus removal membrane to capture the gold colloids for measurement of brightness in a cross section of the virus removal membrane, a value obtained by dividing a standard deviation of a value of an area of a spectrum of variation in the brightness by an average of the value of the area of the spectrum of variation in the brightness is 0.01 or more and 0.30 or less.

Claims (23)

1. A method for manufacturing a virus removal membrane, comprising:

an aging process of maintaining a raw spinning solution at 30° C. or higher and 40° C. or lower for 45 hours or more and 100 hours or less, the raw spinning solution comprising a cuprammonium solution in which cellulose and a silicate are dissolved, and the cellulose being selected from the group consisting of regenerated cellulose and native cellulose;

a membrane formation process of forming a cellulose membrane;

the membrane formation process comprising discharging the raw spinning solution into a coagulation solution and, in a non-solvent induced phase separation, allowing the raw spinning solution to coagulate to form a hollow fiber membrane; and

winding-up the hollow fiber membrane to obtain the virus removal membrane.

2. The method for manufacturing the virus removal membrane according to claim 1 , wherein a cellulose concentration in the raw spinning solution to be discharged in the membrane formation process is 6.0% by weight or more and 8.5% by weight or less.

3. The method for manufacturing the virus removal membrane according to claim 1 , wherein a ratio of a copper concentration to a cellulose concentration in the raw spinning solution to be discharged in the membrane formation process is 0.30 or more and 0.40 or less.

4. The method for manufacturing the virus removal membrane according to claim 1 , wherein a silicon dioxide concentration in the raw spinning solution to be discharged in the membrane formation process is 5 ppm or more and 100 ppm or less.

5. The method for manufacturing the virus removal membrane according to claim 1 , wherein the raw spinning solution further comprises ammonia, and a ratio of an ammonia concentration to a cellulose concentration in the raw spinning solution to be discharged in the membrane formation process is 0.6 or more and 1.0 or less.

6. The method for manufacturing the virus removal membrane according to claim 1 , wherein the raw spinning solution is discharged using an annular spinneret in the membrane formation process.

7. A method for manufacturing a virus removal membrane, comprising:

providing a cuprammonium solution;

dissolving cellulose in the cuprammonium solution and adding a silicate to the cuprammonium solution such that a raw spinning solution that contains cellulose, copper, and silicon dioxide is obtained, the cellulose being selected from the group consisting of regenerated cellulose and native cellulose;

aging the raw spinning solution by maintaining the raw spinning solution at 30° C. or higher and 40° C. or lower for 45 hours or more and 100 hours or less;

providing a coagulation solution;

discharging the raw spinning solution into the coagulation solution and allowing the raw spinning solution to coagulate to form a hollow fiber membrane; and

drying the hollow fiber membrane to obtain the virus removal membrane.

8. The method for manufacturing the virus removal membrane according to claim 1 , comprising:

securing ends of the hollow fiber membrane and stretching the hollow fiber membrane by 1% to 8%,

after stretching, drying the hollow fiber membrane at 30° C. or higher and 60° C. or lower under a pressure of 5 kPa or less.

9. The method for manufacturing the virus removal membrane according to claim 7 , comprising:

securing ends of the hollow fiber membrane and stretching the hollow fiber membrane by 1% to 8%,

wherein, after stretching, drying the hollow fiber membrane at 30° C. or higher and 60° C. or lower under a pressure of 5 kPa or less.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Oct 23, 2025
From: ASAHI KASEI MEDICAL CO., LTD.
To: ASAHI KASEI LIFE SCIENCE CORPORATION
Reel/Frame 072650/0301 →
CHANGE OF ADDRESS Recorded Oct 23, 2025
From: ASAHI KASEI MEDICAL CO., LTD.
To: ASAHI KASEI MEDICAL CO., LTD.
Reel/Frame 073191/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: FUTAMURA, AKIKA; KON, YUSUKE; HONGO, TOMOKO
To: ASAHI KASEI MEDICAL CO., LTD.
Reel/Frame 047626/0767 →
Priority Claims (1)
JP JP2016-072468 · Mar 31, 2016 · national
Continuity (1)
Related Publication 20200298182A1 · Sep 24, 2020